NCT04316546 2026-04-17
MK-7075 (Miransertib) in Proteus Syndrome
National Institutes of Health Clinical Center (CC)
Phase 2 Recruiting
Clinical Trials
4 trialsNCT00001403 2026-04-14
Study of Proteus Syndrome and Related Congenital Disorders
National Institutes of Health Clinical Center (CC)
Recruiting
NCT02594215 2022-06-30
Dose Finding Trial of MK-7075 in Children and Adults With Proteus Syndrome
National Institutes of Health Clinical Center (CC)
Phase 1 Completed
NCT01369953 2018-07-26
Informed Consent for Whole Genome Sequencing: Ideals and Norms Referenced by Early Participants
National Institutes of Health Clinical Center (CC)
Completed